VBS Interventional Vision
VBS Interventional is dedicated to developing innovative technologies to detect and treat vascular-based diseases such as cardiovascular disease, pulmonary vascular disease and cancer.
Many vascular-based diseases are poorly understood, difficult to diagnose, and frequently associated with significant morbidity and mortality because of the inaccessibility of vascular tissue.
In order to enhance and prolong human life, VBS Interventional has created the world’s first endoarterial biopsy catheter, a device designed to obtain biopsy specimens from the inner layers of an artery via a minimally invasive technique.
VBS Interventional is committed to improving current patient therapy and disease management by providing a more comprehensive picture of a patient's vascular pathological, cellular, molecular, and genetic profile through the use of our first product, the endoarterial biopsy catheter.
The endoarterial biopsy catheter will provide a means for monitoring therapeutic interventions, optimizing medical management, customizing diagnosis and therapy, and anticipating future adverse events through the early identification of disease markers in vascular biopsies from patients.
Biopsy samples will undergo histopathological and molecular analysis at our VBS Molecular Diagnostics division to identify the molecular signatures underlying each patient’s vascular disease. Therapeutics can then be administered to precisely target each patient’s disease pathways.
VBS Interventional focuses on improving the diagnosis and medical management of primary and secondary pulmonary hypertension, acute respiratory distress syndrome, lung transplant rejection, vasculitis, pulmonary manifestations of collagen vascular diseases such as lupus and scleroderma, primary and secondary lung cancer, coronary artery disease, peripheral vascular disease, and enabling pharmaceutical drug discovery and development.
CAUTION: Investigational Device.
Limited by Federal law to investigational use.
This device should be used only by physicians with a thorough understanding of percutaneous interventional procedures.
